Guidance on the use of convalescent plasma to treat immunocompromised patients with coronavirus disease 2019

EM Bloch, D Focosi, S Shoham… - Clinical Infectious …, 2023 - academic.oup.com
convalescent plasma from UpToDate; consulting fees from California Institute for Regenerative
Medicine as an advisor on convalescent plasma … -19 Convalescent Plasma for treatment …

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19

RN Rodionov, A Biener, P Spieth, M Achleitner… - The Lancet …, 2021 - thelancet.com
convalescent plasma transfusions.Here, we report our experience with convalescent plasma
administered to 14 patientspatients), allogeneic stem cell transplantation (four patients), or …

COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis

JW Senefeld, M Franchini, C Mengoli… - JAMA Network …, 2023 - jamanetwork.com
… Randomized clinical trials, matched cohort studies, and case report or series on COVID-19
convalescent plasma use in patients who are immunocompromised were included. The …

Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations

D Focosi, M Franchini - Expert review of vaccines, 2022 - Taylor & Francis
… of immunocompromised patients. Among neutralizing antibody-based therapeutics, convalescent
plasma … detailing the efficacy of convalescent plasma in immunocompromised patients. …

Treatment of immunocompromised COVID‐19 patients with convalescent plasma

M Fung, A Nambiar, S Pandey… - Transplant Infectious …, 2021 - Wiley Online Library
… We also report the characteristics of convalescent plasma product from a local blood center
… suggest that convalescent plasma may be safe among immunosuppressed patients with …

[HTML][HTML] Efficacy of convalescent plasma therapy in immunocompromised patients with COVID-19: a case report

G Casarola, M D'Abbondanza, R Curcio, R Alcidi… - Clinical infection in …, 2021 - Elsevier
… Management of immunocompromised COVID-19 patients is the object of current debate.
Accumulating evidence suggest that treatment with high-titer COVID-19 convalescent plasma (…

Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

O Ljungquist, M Lundgren, E Iliachenko… - Infectious …, 2022 - Taylor & Francis
… 76 units of convalescent plasma used by patients in this study… Three patients in this study
received plasma purchased from … Each of these plasma units was produced by pooling plasma

[HTML][HTML] Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients

M Beraud, EG Meyer, M Lozano, A Bah… - … and Apheresis Science, 2022 - Elsevier
… for the treatment of hospitalized patients with COVID-19. … in immunocompromised patients
with COVID-19 and to identify the lessons learned concerning the use of convalescent plasma

Convalescent plasma treatment in patients with Covid-19: a systematic review and meta-analysis

A Jorda, M Kussmann, N Kolenchery… - Frontiers in …, 2022 - frontiersin.org
convalescent plasma in patientsconvalescent plasma in immunocompromised patients
with Covid-19 (35). Considering the overall lack of evidence for convalescent plasma in patients

Recommendations on the use of COVID-19 convalescent plasma to treat immunocompromised patients

M Franchini, A Casadevall, JW Senefeld… - … in Thrombosis and …, 2023 - thieme-connect.com
… Anti-SARS-CoV-2 monoclonal antibodies and convalescent plasma may find application
in early phases of the disease and in selected subgroups of immunosuppressed patients